Evidence map›Paper›PMID 41863236›Full record

ReviewMini reviews in medicinal chemistry2026

A Comprehensive Review on Homology Modelling in Drug Development: Methodologies, Tools, and Evaluation.

Priyanshu Nema, Arpana Purohit, Vandana Soni, Sushil Kumar Kashaw

Abstract readReview
PubMed Publisher
In one paragraph

Review in Mini reviews in medicinal chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Priyanshu NemaIntegrated Drug Discovery Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Central University, Sagar (MP), India.
Arpana PurohitIntegrated Drug Discovery Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Central University, Sagar (MP), India.
Vandana SoniIntegrated Drug Discovery Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Central University, Sagar (MP), India.
Sushil Kumar KashawIntegrated Drug Discovery Research Laboratory, Department of Pharmaceutical Sciences, Dr. Hari Singh Gour Central University, Sagar (MP), India.

Funding

University Grants Commission Y22454401,Y22454402
6 · The paper itself

Abstract

The large accumulation of genomic and proteomic data has clearly established the need for accurate prediction of protein structure, especially with a view to enabling structurebased drug design. There are numerous ways to do this on computers these days, but one that distinctly stands out is homology modeling since it is fast, cheap, and consistent. It forecasts three-dimensional protein structures with unrecognized geometries by examining how they have evolved to date. This article provides an in-depth and up-to-date review of homology modeling. It addresses important steps, like discovering templates, sequence alignment, model building, loop refinement, side chain modeling, and structure validation. We have examined in detail the widely used tools, such as BLAST, MODELLER, Swiss-Model, SCWRL, PROCHECK, ProSA, and VERIFY3D. Also, it has been covered how artificial intelligence and machine learning can enhance these processes to be more precise, where little homology exists. Currently, a lot of focus is being placed on loop modeling problems, choosing a template, and structural validation procedures, like root mean square deviation (RMSD), Z-score, and Ramachandran plot statistics. In addition, we have examined how homology modeling is used in ligand docking and in lead optimization at the system level. The review offers great advice on how to speed up the drug-development process, especially for proteins that prove hard to crystallize or solve by X-ray crystallography. It does so by integrating concepts from bioinformatics, computational genomics, and structural biology into its design. We herein bridge traditional techniques and current computer technology to offer drug scientists a useful tool.

Indexed as

Drug DevelopmentModels, MolecularProteinsHumansProtein ConformationProteinsblastComparative modellingdatabasefastaprocheckproteinsvalidation

Identifiers

PMID41863236

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.